This work aimed to deepen the understanding of EGFR activation and regulation mechanisms in GBM by revealing the complexity of its activation pathways, highlighting the challenges in targeting EGFR in GBM, particularly when compared with its more successful inhibition in LUAD. This evidence concerns the gene EGFR and glioblastoma.